• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择乳房切除术与保乳手术加放疗:乳腺癌幸存者的经历

Choosing Mastectomy vs. Lumpectomy-With-Radiation: Experiences of Breast Cancer Survivors.

作者信息

Admoun Claudia, Mayrovitz Harvey

机构信息

Surgical Oncology, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA.

Medical Education, Nova Southeastern University Dr. Kiran C. Patel College of Allopathic Medicine, Davie, USA.

出版信息

Cureus. 2021 Oct 2;13(10):e18433. doi: 10.7759/cureus.18433. eCollection 2021 Oct.

DOI:10.7759/cureus.18433
PMID:34729260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8555933/
Abstract

Background Annually about 280,000 women are diagnosed with breast cancer. Treatment options depend on age, comorbidities, tumor stage, grade, size, and other factors. Often, patients must decide between two surgical treatment options: mastectomy or lumpectomy-with-radiation herein simply called a lumpectomy. Since both offer similar survival outcomes, the choice ultimately is the patient's. However, most rely on inputs from doctors, family, friends, personal research, and other actions. We believe decision-making processes for future patients will be aided if experiences of prior breast cancer survivors are known. This study's aim is to provide such information. Methods Feedback from prior breast cancer survivors was obtained using a 19-question survey distributed online to multiple breast cancer support groups. It focused on issues relevant to choosing between the two surgical options including, post-surgical complications, breast reconstruction, chronic pain, cosmetics, and surgery-choice satisfaction. Results Respondents (N=1606) had a median age of 49 years (range 26 to 88 years) and had a median body mass index (BMI) of 26.6 Kg/m. There were 978 mastectomy patients (60.9%) and 628 lumpectomy patients (39.1%). With regard to post-surgical reconstruction, 64.2% of mastectomy respondents and 13.5% of lumpectomy respondents decided to undergo breast cancer reconstruction following breast cancer surgery. Almost all (99.8%) of lumpectomy respondents had radiation side-effects; with skin irritation and thickening and chest wall tenderness being the most common. Among mastectomy patients, 94.3% had one or more complications; loss-or-changes in nipple or breast sensation, uneven breasts, chest wall tenderness, and breast swelling were the most common complications. Post-surgical pain lasting six months or more was experienced by a smaller percentage of mastectomy vs. lumpectomy patients (64.1% vs. 78%, p <0.00001). Mastectomy patients were also less likely to have pain that was persistent and present up to the time of the survey (35.4% vs. 46.0%, p=0.0002). With respect to cosmetic outcomes, mastectomy patients vs. lumpectomy patients were less likely to be either satisfied or very satisfied (52.2% vs. 62.7%, p=0.00004). Overall satisfaction of surgical treatment was 70.9% for mastectomy patients and 68.6% for lumpectomy patients. Conclusion Based on the experiences of these breast cancer survivors, mastectomy is associated with less chronic pain frequency and lower incidence of post-surgical side effects compared to lumpectomy. However, mastectomy is associated with lower cosmetic satisfaction. Breast cancer survivors that underwent a lumpectomy, reported being more satisfied with cosmetic outcomes but almost all reported radiation side-effects with skin thickening listed as the most common. Lumpectomy was also associated with higher chronic pain frequency compared to mastectomy. The overall surgical treatment satisfaction reported by mastectomy and lumpectomy respondents was similar. The composite findings will provide information that will aid future breast cancer patients in making a decision between having a mastectomy or a lumpectomy.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc2d/8555933/2cf0dfc35955/cureus-0013-00000018433-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc2d/8555933/a08e409677f2/cureus-0013-00000018433-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc2d/8555933/042df8fa9695/cureus-0013-00000018433-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc2d/8555933/2cf0dfc35955/cureus-0013-00000018433-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc2d/8555933/a08e409677f2/cureus-0013-00000018433-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc2d/8555933/042df8fa9695/cureus-0013-00000018433-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc2d/8555933/2cf0dfc35955/cureus-0013-00000018433-i03.jpg
摘要

背景

每年约有28万名女性被诊断出患有乳腺癌。治疗方案取决于年龄、合并症、肿瘤分期、分级、大小及其他因素。通常,患者必须在两种手术治疗方案之间做出抉择:乳房切除术或保乳手术加放疗(本文简称为保乳手术)。由于二者的生存结果相似,最终选择权在患者手中。然而,大多数患者会依赖医生、家人、朋友的建议、个人研究及其他行为。我们认为,如果了解先前乳腺癌幸存者的经历,将有助于未来患者的决策过程。本研究旨在提供此类信息。

方法

通过在线向多个乳腺癌支持小组发放一份包含19个问题的调查问卷,获取先前乳腺癌幸存者的反馈。问卷聚焦于两种手术方案选择相关的问题,包括术后并发症、乳房重建、慢性疼痛、外观及手术选择满意度。

结果

受访者(N = 1606)的中位年龄为49岁(范围26至88岁),中位体重指数(BMI)为26.6 Kg/m²。乳房切除术患者978例(60.9%),保乳手术患者628例(39.1%)。关于术后重建,64.2%的乳房切除术受访者和13.5%的保乳手术受访者决定在乳腺癌手术后进行乳房重建。几乎所有(99.8%)的保乳手术受访者都有放疗副作用;皮肤刺激、增厚及胸壁压痛最为常见。在乳房切除术患者中,94.3%有一项或多项并发症;乳头或乳房感觉丧失或改变、乳房不对称、胸壁压痛及乳房肿胀是最常见的并发症。乳房切除术患者术后持续疼痛六个月或更长时间的比例低于保乳手术患者(64.1%对78%,p < 0.00001)。乳房切除术患者在调查时仍有持续性疼痛的可能性也较小(35.4%对46.0%,p = 0.0002)。在外观效果方面,乳房切除术患者对外观满意或非常满意的可能性低于保乳手术患者(52.2%对62.7%,p = 0.00004)。乳房切除术患者对手术治疗的总体满意度为70.9%,保乳手术患者为68.6%。

结论

基于这些乳腺癌幸存者的经历,与保乳手术相比,乳房切除术的慢性疼痛频率较低,术后副作用发生率较低。然而,乳房切除术的外观满意度较低。接受保乳手术的乳腺癌幸存者对外观效果更满意,但几乎所有人都报告有放疗副作用,其中皮肤增厚最为常见。与乳房切除术相比,保乳手术的慢性疼痛频率也更高。乳房切除术和保乳手术受访者报告的总体手术治疗满意度相似。这些综合结果将为未来乳腺癌患者在乳房切除术和保乳手术之间做出决策提供帮助。

相似文献

1
Choosing Mastectomy vs. Lumpectomy-With-Radiation: Experiences of Breast Cancer Survivors.选择乳房切除术与保乳手术加放疗:乳腺癌幸存者的经历
Cureus. 2021 Oct 2;13(10):e18433. doi: 10.7759/cureus.18433. eCollection 2021 Oct.
2
Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.导管原位癌的治疗:利弊平衡尚不确定。
Prescrire Int. 2013 Dec;22(144):298-303.
3
Breast-Specific Sensuality and Appearance Satisfaction: Comparison of Breast-Conserving Surgery and Nipple-Sparing Mastectomy.乳房特异性感觉和外观满意度:保乳手术与保留乳头乳晕的乳房切除术比较。
J Am Coll Surg. 2020 Jun;230(6):990-998. doi: 10.1016/j.jamcollsurg.2020.02.048. Epub 2020 Apr 6.
4
Postmastectomy breast reconstruction after previous lumpectomy and radiation therapy: analysis of complications and satisfaction.先前接受保乳手术及放疗后的乳房切除术后乳房重建:并发症及满意度分析
Ann Plast Surg. 2011 May;66(5):444-51. doi: 10.1097/SAP.0b013e3182166b81.
5
Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors.乳房重建手术在乳腺癌幸存者身体和情感结局中的作用。
J Natl Cancer Inst. 2000 Sep 6;92(17):1422-9. doi: 10.1093/jnci/92.17.1422.
6
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
7
Body mass index (BMI), postoperative appearance satisfaction, and sexual function in breast cancer survivorship.体重指数(BMI)、术后外观满意度与乳腺癌生存者的性功能。
J Cancer Surviv. 2018 Feb;12(1):127-133. doi: 10.1007/s11764-017-0651-y. Epub 2017 Oct 17.
8
Longitudinal Trends in Patient-Reported Outcomes in the First Year After Lumpectomy Versus Mastectomy.保乳术与乳房切除术患者术后第一年报告结局的纵向趋势
Ann Surg Oncol. 2024 Oct;31(11):7597-7606. doi: 10.1245/s10434-024-15795-8. Epub 2024 Jul 18.
9
Long-term Patient-Reported Outcomes in Older Breast Cancer Survivors: A Population-Based Survey Study.老年乳腺癌幸存者的长期患者报告结局:一项基于人群的调查研究。
Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):882-890. doi: 10.1016/j.ijrobp.2017.11.047. Epub 2017 Dec 9.
10
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.BRCA 突变携带者的双侧预防性乳房切除术:外科医生需要了解的内容。
Ann Ital Chir. 2019;90:1-2.

引用本文的文献

1
Diagnosis and Management of Neuropathic Breast Pain.神经性乳腺疼痛的诊断与管理
Plast Reconstr Surg Glob Open. 2024 Dec 23;12(12):e6266. doi: 10.1097/GOX.0000000000006266. eCollection 2024 Dec.
2
Harnessing curcumin and nanotechnology for enhanced treatment of breast cancer bone metastasis.利用姜黄素和纳米技术增强乳腺癌骨转移的治疗效果。
Discov Nano. 2024 Nov 11;19(1):177. doi: 10.1186/s11671-024-04126-1.
3
Breast Cancer: The Psychological Impact of Diagnosis, Treatment, and Remission.乳腺癌:诊断、治疗及缓解的心理影响

本文引用的文献

1
The risk of contralateral breast cancer: a SEER-based analysis.基于 SEER 的分析:对侧乳腺癌风险。
Br J Cancer. 2021 Aug;125(4):601-610. doi: 10.1038/s41416-021-01417-7. Epub 2021 May 26.
2
Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: A Swedish National 6-Year Follow-up of 48 986 Women.保乳与乳房切除术治疗后的生存比较:调整合并症和社会经济地位因素后,瑞典全国 6 年随访 48986 例女性。
JAMA Surg. 2021 Jul 1;156(7):628-637. doi: 10.1001/jamasurg.2021.1438.
3
Cancer Statistics, 2021.癌症统计数据,2021.
Cureus. 2024 Oct 4;16(10):e70814. doi: 10.7759/cureus.70814. eCollection 2024 Oct.
4
Differentiating Primary and Recurrent Lesions in Patients with a History of Breast Cancer: A Comprehensive Review.乳腺癌病史患者原发性和复发性病变的鉴别:一项综述。
Galen Med J. 2024 Apr 22;13:e3340. doi: 10.31661/gmj.v13i.3340. eCollection 2024.
5
Variation in surgical treatment by body mass index in patients with invasive lobular carcinoma of the breast.体质量指数对乳腺浸润性小叶癌患者手术治疗的影响。
Breast Cancer Res Treat. 2024 Dec;208(3):569-575. doi: 10.1007/s10549-024-07452-1. Epub 2024 Aug 11.
6
Longitudinal Trends in Patient-Reported Outcomes in the First Year After Lumpectomy Versus Mastectomy.保乳术与乳房切除术患者术后第一年报告结局的纵向趋势
Ann Surg Oncol. 2024 Oct;31(11):7597-7606. doi: 10.1245/s10434-024-15795-8. Epub 2024 Jul 18.
7
The evolvement of breast cancer therapies: What we have done and where all these head off.乳腺癌治疗的演变:我们已经做了什么以及这一切将走向何方。
Saudi Med J. 2024 Apr;45(4):331-340. doi: 10.15537/smj.2024.45.4.20230492.
8
Reducing re-excision rates in breast conserving surgery with Margin Probe: systematic review.Margin Probe 在保乳手术中降低切缘再次阳性率的系统评价。
Br J Surg. 2024 Jan 3;111(1). doi: 10.1093/bjs/znad335.
9
Postmastectomy Functional Impairments.乳腺癌术后功能障碍。
Curr Oncol Rep. 2023 Dec;25(12):1445-1453. doi: 10.1007/s11912-023-01474-6. Epub 2023 Nov 13.
10
Guidelines for breast cancer management in Bosnia and Herzegovina.波斯尼亚和黑塞哥维那乳腺癌管理指南。
Biomol Biomed. 2023 Feb 1;23(1):2-14. doi: 10.17305/bjbms.2022.7504.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
4
The impact of scars on health-related quality of life after breast surgery: a qualitative exploration.乳房手术后疤痕对健康相关生活质量的影响:定性探讨。
J Cancer Surviv. 2021 Apr;15(2):224-233. doi: 10.1007/s11764-020-00926-3. Epub 2020 Aug 20.
5
Breast-Conserving Therapy is Associated with Improved Survival Compared with Mastectomy for Early-Stage Breast Cancer: A Propensity Score Matched Comparison Using the National Cancer Database.与乳房切除术相比,保乳治疗与早期乳腺癌患者生存率提高相关:一项使用国家癌症数据库的倾向评分匹配比较研究
Ann Surg Oncol. 2021 Feb;28(2):914-919. doi: 10.1245/s10434-020-08829-4. Epub 2020 Jul 13.
6
Breast Reconstruction Does Not Increase the Incidence of Postmastectomy Pain Syndrome: Results of a Meta-Analysis.乳房重建不会增加乳房切除术后疼痛综合征的发生率:一项荟萃分析的结果。
Ann Plast Surg. 2020 May;84(5):611-617. doi: 10.1097/SAP.0000000000002062.
7
A Reappraisal of the Comparative Effectiveness of Lumpectomy Versus Mastectomy on Breast Cancer Survival: A Propensity Score-Matched Update From the National Cancer Data Base (NCDB).保乳术与乳房切除术治疗乳腺癌生存的比较效果再评价:来自国家癌症数据库(NCDB)的倾向评分匹配更新。
Clin Breast Cancer. 2019 Jun;19(3):e481-e493. doi: 10.1016/j.clbc.2019.02.006. Epub 2019 Feb 21.
8
Postoperative outcomes of breast reconstruction after mastectomy: A retrospective study.乳房切除术后乳房重建的术后结果:一项回顾性研究。
Medicine (Baltimore). 2018 Feb;97(5):e9766. doi: 10.1097/MD.0000000000009766.
9
THE EPIDEMIOLOGY AND OUTCOMES OF BREAST CANCER SURGERY.乳腺癌手术的流行病学及结果
Trans Am Clin Climatol Assoc. 2016;127:46-58.
10
Determinants for patient satisfaction regarding aesthetic outcome and skin sensitivity after breast-conserving surgery.保乳手术后患者对美学效果和皮肤敏感性满意度的决定因素。
World J Surg Oncol. 2016 Dec 7;14(1):303. doi: 10.1186/s12957-016-1053-8.